In this cohort, the use of high- and super-sensitivity cardiac troponin I assays was associated with significantly increased predictive ability for cardiovascular events, including incident heart failure and myocardial infarction, even after adjustment for traditional risk factors, C-reactive protein, and N-terminal pro-brain natriuretic peptide. The gene discussed is TNNI3; the disease is heart failure.